[HTML][HTML] Post-thyroidectomy hypothyroidism and thyroid hormone supplementation: a narrative review of the history, treatment, and patient experience

JA Brooks, JB Fontanarosa, B Gigliotti - Annals of Thyroid, 2023 - aot.amegroups.org
Methods: Review of English language studies on history, diagnosis and management of
hypothyroidism following thyroidectomy, as well as relevant QoL assessment, conducted by …

Potential Bias About the Association Between Weight Loss Surgery and COVID-19 Infection

PE Kao, A Ker, JCC Wei - JAMA surgery, 2022 - jamanetwork.com
In Reply We would like to thank Kao and colleagues for their interest in our recent
publication1 in JAMA Surgery, which was conducted to examine whether a successful …

Étendue de la thyroïdectomie: quand peut-on réaliser une lobo-isthmectomie? Recommandations de l'AFCE (Association francophone de chirurgie endocrinienne) …

S Deguelte, PA Colas, C Guerin, S Leboulleuxt… - Journal de Chirurgie …, 2023 - Elsevier
Résumé Ces recommandations détaillent les risques de la lobo-isthmectomie (LI) et de la
thyroïdectomie totale (TT), et la place de ces deux procédures dans les principales …

[HTML][HTML] Survival rate between total thyroidectomy and lobectomy in papillary thyroid cancer

SS Alhanafy, AAE Elsisy, AB Alanazi… - The Egyptian Journal …, 2024 - journals.lww.com
Background Regarding papillary thyroid cancer, comparisons between lobectomy (LT) and
total thyroidectomy (TT) have not addressed major risks to reliable conclusions drawn from …

Concerns Over Thyroid Cancer Surgeries and Quality of Life

P Sun, H Yang, W Niu - JAMA surgery, 2022 - jamanetwork.com
To the Editor In reference to the recent publication by Chen and colleagues1 regarding the
extent of surgery for differentiated thyroid cancer (DTC) associated with health-related …

Concerns Over Thyroid Cancer Surgeries and Quality of Life—Reply

W Chen, J Li, W Lv - JAMA surgery, 2022 - jamanetwork.com
In Reply We would like to reply to the concerns from Sun and colleagues on our recently
published article. 1 Sun and colleagues kindly raised 2 concerns. The first concern is …

[PDF][PDF] Обґрунтування органозберігаючої тактики хірургічного лікування папілярного раку щитоподібної залози

ДМ Квітка - 2023 - ir.librarynmu.com
Квітка Дмитро Миколайович ДИСЕРТАЦІЯ Page 1 МІНІСТЕРСТВО ОХОРОНИ ЗДОРОВ’Я
УКРАЇНИ НАЦІОНАЛЬНИЙ МЕДИЧНИЙ УНІВЕРСИТЕТ ІМЕНІ ООБОГОМОЛЬЦЯ …

Patient‑reported outcome measures for assessing health‑related quality of life in patients with differentiated thyroid cancer: a systematic review

L Xiong, L Liu, Y Xiang, C Li, W Dai, J Hu… - International Journal of … - journals.lww.com
Background: Patient-reported outcome measures (PROMs) have become important tools for
evaluating health-related quality of life (HRQOL) in patients with differentiated thyroid cancer …

Impact of different categories of intermediate risk factors on the recurrence of papillary thyroid carcinoma: a retrospective cohort study

Q Chen, X Zou, F Liu, A Su, Y Jiang, T Wei… - International Journal of … - journals.lww.com
Background: Data regarding the long-term recurrence in patients with intermediate-risk
papillary thyroid carcinoma (PTC) are limited. The aim of this study was to assess the impact …

[HTML][HTML] The ambiguity of intermediate risk thyroid cancer: multifocality as a risk factor

AJ Bastien, JD Moses, AS Ho - Annals of Thyroid, 2022 - aot.amegroups.org
Thyroid cancer is projected to be the fourth leading cancer diagnosis by 2030 (1, 2). In
general, these patients have an excellent prognosis with an overall long-term survival …